Roche introduces molecular testing solutions to differentiate Covid-19 variants

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta

IFF to acquire contract manufacturer of dietary supplements Health Wright Products

The sale is expected to close in the first quarter of 2022

Skye Air Mobility to deploy drones to enhance Redcliffe Labs services

Urban, semi-urban and remote corners of the country will be catered using drone delivery technology

Redcliffe Labs appoints Abhay Singavi as Chief Business Officer

Takes charge to lead business innovation, strategy, alliance & partnerships

Green chemistry approaches to synthesis could make a big difference to pharma product outputs

Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies

Redcliffe Labs chalks out aggressive expansion plans

It plans to add over 1000 employees over the next six months

Antengene and MindRank AI to advance the development of difficult-to-drug molecular targets

Both companies aim to improve the efficiency and success rate of the current drug discovery process.

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms

Leeford scales science-led skincare bet with Alite as acne-care demand surges

Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise

Bayer unites 700 doctors, sets Guinness World Record for maternal nutrition advocacy in India